Bisphosphonates vs placebo/observation
Overall survival: pre‐ or perimenopausal women · women with early breast cancer
Bisphosphonates showed no clear difference in overall survival: pre‐ or perimenopausal women compared with placebo/observation (high certainty).
1 finding from 1 review
- HR 1.03 [0.86, 1.22]2 studies · 3501 participantsHigh